135 related articles for article (PubMed ID: 35699271)
1.
Chen B; Hong S; Dai X; Li X; Huang Q; Sun T; Cao D; Zhang H; Chai Z; Diwu J; Wang S
J Am Chem Soc; 2022 Jun; 144(25):11054-11058. PubMed ID: 35699271
[TBL] [Abstract][Full Text] [Related]
2. Hexadentate β-Dicarbonyl(bis-catecholamine) Ligands for Efficient Uranyl Cation Decorporation: Thermodynamic and Antioxidant Activity Studies.
Zhang Q; Jin B; Zheng T; Tang X; Guo Z; Peng R
Inorg Chem; 2019 Nov; 58(21):14626-14634. PubMed ID: 31613591
[TBL] [Abstract][Full Text] [Related]
3. Cinnamic Acid: A Low-Toxicity Natural Bidentate Ligand for Uranium Decorporation.
Liu Y; Zhao B; He P; Wang Z; Tang K; Mou Z; Tan Y; Wu L; Chen G; Li X; Zhu L; Duan T
Inorg Chem; 2024 Apr; 63(16):7464-7472. PubMed ID: 38598182
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-2-Pyrrolidinone as a Potential Bidentate Ligand for in Vivo Chelation of Uranyl with Low Cytotoxicity and Moderate Decorporation Efficacy: A Solution Thermodynamics, Structural Chemistry, and in Vivo Uranyl Removal Survey.
Wang X; Wu S; Guan J; Chen L; Shi C; Wan J; Liu Y; Diwu J; Wang J; Wang S
Inorg Chem; 2019 Mar; 58(5):3349-3354. PubMed ID: 30735401
[TBL] [Abstract][Full Text] [Related]
5. A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.
Wang X; Dai X; Shi C; Wan J; Silver MA; Zhang L; Chen L; Yi X; Chen B; Zhang D; Yang K; Diwu J; Wang J; Xu Y; Zhou R; Chai Z; Wang S
Nat Commun; 2019 Jun; 10(1):2570. PubMed ID: 31239437
[TBL] [Abstract][Full Text] [Related]
6. Structural and Thermodynamics Studies on Polyaminophosphonate Ligands for Uranyl Decorporation.
Ye G; Roques J; Solari PL; Den Auwer C; Jeanson A; Brandel J; Charbonnière LJ; Wu W; Simoni É
Inorg Chem; 2021 Feb; 60(4):2149-2159. PubMed ID: 33522798
[TBL] [Abstract][Full Text] [Related]
7. Amidoxime-Functionalized Covalent Organic Nanosheets for Sequestration of Uranium In Vivo.
Chen L; Bai R; Wang X; Zhang Y; He L; Zhang M; Chong Y; Chai Z; Wang XF; Diwu J
ACS Appl Bio Mater; 2020 Dec; 3(12):8731-8738. PubMed ID: 35019644
[TBL] [Abstract][Full Text] [Related]
8. Polyethyleneimine methylphosphonate: towards the design of a new class of macromolecular actinide chelating agents in the case of human exposition.
Lahrouch F; Sofronov O; Creff G; Rossberg A; Hennig C; Den Auwer C; Di Giorgio C
Dalton Trans; 2017 Oct; 46(40):13869-13877. PubMed ID: 28971198
[TBL] [Abstract][Full Text] [Related]
9. Perilla frutescens: A new strategy for uranium decorporation.
Cao Y; Wang Z; Song W; Liu Y; Zhao Q; Li W; Zheng C; Li W; Chen Z; Zhu L; Duan T; Li X
Chemosphere; 2024 Feb; 350():141066. PubMed ID: 38159731
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Uranium Sequestration using a Nanoscale Metal-Organic Framework.
Wang X; Chen L; Bai Z; Zhang D; Guan J; Zhang Y; Shi C; Diwu J
Angew Chem Int Ed Engl; 2021 Jan; 60(3):1646-1650. PubMed ID: 33029917
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
Abergel RJ; Durbin PW; Kullgren B; Ebbe SN; Xu J; Chang PY; Bunin DI; Blakely EA; Bjornstad KA; Rosen CJ; Shuh DK; Raymond KN
Health Phys; 2010 Sep; 99(3):401-7. PubMed ID: 20699704
[TBL] [Abstract][Full Text] [Related]
12. Folding Dynamics of 3,4,3-LI(1,2-HOPO) in Its Free and Bound State with U
Wang Q; Liu Z; Song YF; Wang D
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500244
[TBL] [Abstract][Full Text] [Related]
13. Boosting Simultaneous Uranium Decorporation and Reactive Oxygen Species Scavenging Efficiency by Lacunary Polyoxometalates.
Shi P; Wang X; Zhang H; Sun Q; Li A; Miao Y; Shi C; Guan J; Gong S; Diwu J
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54423-54430. PubMed ID: 36455139
[TBL] [Abstract][Full Text] [Related]
14. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
Durbin PW; Kullgren B; Xu J; Raymond KN
Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
[TBL] [Abstract][Full Text] [Related]
15. Hexadentate terephthalamide(bis-hydroxypyridinone) ligands for uranyl chelation: structural and thermodynamic consequences of ligand variation.
Szigethy G; Raymond KN
J Am Chem Soc; 2011 May; 133(20):7942-56. PubMed ID: 21542587
[TBL] [Abstract][Full Text] [Related]
16. Hinokitiol, an Advanced Bidentate Ligand for Uranyl Decorporation.
Guan J; Wang X; Shi P; Chen L; Chen B; Zhang Y; Chen Y; Xu Y; Chai Z; Wang S; Diwu J
Inorg Chem; 2022 Mar; 61(9):3886-3892. PubMed ID: 35200006
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in uranyl binding in proteins thanks to biomimetic peptides.
Garai A; Delangle P
J Inorg Biochem; 2020 Feb; 203():110936. PubMed ID: 31864150
[TBL] [Abstract][Full Text] [Related]
18. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions.
Kullgren B; Jarvis EE; An DD; Abergel RJ
Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518
[TBL] [Abstract][Full Text] [Related]
19. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation.
Sawicki M; Lecerclé D; Grillon G; Le Gall B; Sérandour AL; Poncy JL; Bailly T; Burgada R; Lecouvey M; Challeix V; Leydier A; Pellet-Rostaing S; Ansoborlo E; Taran F
Eur J Med Chem; 2008 Dec; 43(12):2768-77. PubMed ID: 18313802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
